Pregabalin 50228-0652
Product NDC
50228-0652- Manufacturer
- Sciegen Pharmaceuticals, Inc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- December 10, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA208677
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pregabalin | 300 mg/1 |
Packaging Options(2)
500 CAPSULE in 1 BOTTLE (50228-652-05)
90 CAPSULE in 1 BOTTLE (50228-652-90)